z-logo
open-access-imgOpen Access
Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports
Author(s) -
Yan Ji,
Rachel I. Vogel,
Emil Lou
Publication year - 2015
Publication title -
neuro-oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 14
eISSN - 2054-2585
pISSN - 2054-2577
DOI - 10.1093/nop/npv059
Subject(s) - temozolomide , medicine , oncology , pituitary adenoma , adenoma , chemotherapy
Pituitary carcinomas (PC) and atypical pituitary adenomas (APA) are rare variants of pituitary tumors for which no evidence-based treatment currently exists. We sought to determine whether temozolomide represents an effective chemotherapeutic option for patients with PC and APA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom